Reports from Workshops

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

Price: £40.00

Session 5

Moderated by Sonja Pumpluen, Head Global Drug Regulatory Affairs, Actelion, Switzerland

Closing Remarks

Paolo M. Biffignandi, TOPRA President, CEO, VI.REL Pharma S.a.a., Italy

Delegates were divided into groups of 10 and discussed case studies with a panel representing PDCO members, the European Medicines Agency and industry experts

Ali Harrison, AstraZeneca - article 8
Judith Creba, Novartis - article 7
Geert Preuveneers, Merck Sharp & Dohme - article 7
Gloria Garcia-Palacios, Sanofi Aventis - article 7
Suman Dhir, J&J - article 7
Anu Tummavuori, Celgene - orphan
Bao Phan, Roche - article 7
Laila Narouz-Ott, Bayer Schering Pharma - article 8